Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -5.08% | +3.70% |
2020 | Mark Corrigan Departs as CEO from Correvio Pharma Corp | CI |
2020 | Justin Renz, CFO Departs from Correvio Pharma Corp | CI |
Chart calendar Correvio Pharma Corp.
Upcoming events on Correvio Pharma Corp.
No events available
Past events on Correvio Pharma Corp.
2020-06-28 | Q1 2020 Earnings Release |
2020-05-15 13:00 | Annual General Meeting |
2020-03-30 07:00 | FY 2019 Earnings Release |
2019-12-03 12:50 | Piper Jaffray Healthcare Conference |
2019-11-18 11:30 | American Heart Association Scientific Meeting - Poster #2028 |
2019-11-14 08:30 | Q3 2019 Earnings Call |
2019-11-14 07:00 | Q3 2019 Earnings Release |
2019-10-04 10:40 | Cantor Global Health Care Conference |
2019-09-10 13:45 | H.C. Wainwright Global Investor Conference |
2019-09-02 08:00 | European Society of Cardiology Congress |
2019-08-30 | European Society of Cardiology Congress |
2019-08-14 08:30 | Interim 2019 Earnings Call |
2019-08-14 07:00 | Interim 2019 Earnings Release |
2019-06-18 12:30 | Annual General Meeting |
2019-05-08 08:30 | Q1 2019 Earnings Call |
2019-05-08 08:00 | Q1 2019 Earnings Release |
2019-04-16 06:30 | European Clinical Microbiology and Infectious Disease Congress - Poster Number: #P2849 |
2019-04-16 06:30 | European Clinical Microbiology and Infectious Disease Congress - Poster Number: #P2296 |
2019-04-15 10:00 | European Clinical Microbiology and Infectious Disease Congress - Oral Presentation Number 00920 |
2019-04-15 07:30 | European Clinical Microbiology and Infectious Disease Congress - Poster Number: #P1865 |
Annual results
Fiscal Period | December | 2015 | 2016 | 2017 | 2018 | 2019 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 20,8 23,6 -11.91% | 25,3 24,5 3.07% | 24,0 24,9 -3.48% | 28,7 28,1 2.06% | 32,6 32,8 -0.65% |
EBITDA Million USD | Released Forecast Spread | -19,9 -16,7 -18.86% | -11,6 -11,7 1.16% | -19,5 -19,2 -1.36% | -22,2 -24,8 10.49% | -23,5 -23,4 -0.38% |
EBIT Million USD | Released Forecast Spread | -22,1 -18,7 -18.26% | -14,6 -13,5 -7.76% | -23,0 -21,0 -9.59% | -26,3 -27,8 5.15% | -27,5 -26,6 -3.36% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,5 -20,4 -19.81% | -19,5 -18,1 -7.65% | -29,4 -27,0 -9.11% | -16,5 -16,1 -2.81% | -35,0 -35,5 1.29% |
Net income Million USD | Released Forecast Spread | -24,5 -21,5 -13.88% | -19,6 -18,4 -6.68% | -29,8 -27,1 -10.14% | -16,6 -16,2 -2.37% | -35,2 -34,7 -1.34% |
EPS USD | Released Forecast Spread | -1,34 -1,19 -12.84% | -0,78 -0,72 -8.59% | -0,90 -0,84 -7.78% | -0,47 -0,47 -0.43% | -0,79 -0,78 -1.72% |
Announcement Date | 10/03/16 | 07/03/17 | 13/03/18 | 13/03/19 | 30/03/20 |
Past sector events for Correvio Pharma Corp.
- Stock Market
- Equities
- CORV Stock
- Calendar Correvio Pharma Corp.